WuXi AppTec (WUXAY) Stock Price, News & Analysis

Company Overview

WuXi AppTec is a contract research, development and manufacturing organization (CRDMO) that provides services to pharmaceutical, biotechnology and medical-device companies. Its offerings span the drug-development process, including early-stage discovery, medicinal and synthetic chemistry, biology research, analytical testing, preclinical studies, clinical research support, process development and commercial manufacturing.

The company supports a broad range of therapeutic programs, with capabilities covering small-molecule drugs, biologics, chemical and pharmaceutical products, and cell and gene therapies. Its services are designed to help customers advance potential medicines from laboratory research through clinical development and production, including regulatory and quality-related support.

Founded in 2000, WuXi AppTec is headquartered in Wuxi, China, and operates research, testing and manufacturing facilities in China, the United States, Europe and other international markets. The company was founded by Dr. Ge Li, who has been associated with its leadership since its establishment. WuXi AppTec serves customers worldwide, including pharmaceutical companies, emerging biotechnology firms and medical-device developers.

Key Stats

• Today's Range: $26.67 to $28.45
• 50-Day Range: $21.61 to $28.00
• 52-Week Range: $12.45 to $28.69
• Volume: 183,000 shs
• Average Volume: 10,926 shs
• Market Capitalization: $14.55 billion
• P/E Ratio: N/A
• Dividend Yield: 0.78%
• Price Target: N/A
• Consensus Rating: Moderate Buy

WuXi AppTec Stock Analysis - MarketRank™

WuXi AppTec scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

WuXi AppTec has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

WuXi AppTec has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 20.00%

Earnings Growth

Earnings for WuXi AppTec are expected to grow by 20.00% in the coming year, from $1.00 to $1.20 per share.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of WuXi AppTec has been sold short.

Short Interest Ratio / Days to Cover

WuXi AppTec has a short interest ratio ("days to cover") of 2.85, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in WuXi AppTec has recently increased by 47.68%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

WuXi AppTec has a dividend yield of 0.80%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

WuXi AppTec does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, WuXi AppTec will have a dividend payout ratio of 17.50% next year. This indicates that WuXi AppTec will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.9 / 5
• News Sentiment: -0.59

News Sentiment

WuXi AppTec has a news sentiment score of -0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for WuXi AppTec this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, WuXi AppTec insiders have not sold or bought any company stock.

Percentage Held by Institutions

WuXi AppTec has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 4/27/2026
• Today: 10/11/2026
• Next Earnings (Estimated): 10/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: OTCMKTS:WUXAY
• CIK: N/A
• Web: www.wuxiapptec.com
• Phone: 862120663091
• Fax: N/A
• Employees: 33,834
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 541,470,000
• Free Float: N/A
• Market Cap: $14.55 billion
• Optionable: Not Optionable
• Beta: N/A